MELBOURNE, Australia – With the global regenerative medicine market growing at 23 percent annually, Australia is well-positioned to play a significant role in that market, experts said during the AusBiotech conference.
MELBOURNE, Australia – Some big deals in the biopharma space in Australia over the last year have gotten the attention of big pharma, and the sector is keyed up over the courtship possibilities.
MELBOURNE, Australia – With the global regenerative medicine market growing at 23 percent annually, Australia is well-positioned to play a significant role in that market, experts said during the AusBiotech conference.
MELBOURNE, Australia – Some big deals in the biopharma space in Australia over the last year have gotten the attention of big pharma, and the sector is keyed up over the courtship possibilities.
PERTH, Australia – After completing its IPO in July, Sydney-based Noxopharm Pty Ltd. expects to have the first three clinical trials of its lead compound up and running in the first quarter of 2017.
MELBOURNE, Australia – The Australian government is injecting more funding into its life sciences sector to help it become more globally competitive in commercializing products.
PERTH, Australia – After completing its IPO in July, Sydney-based Noxopharm Pty Ltd. expects to have the first three clinical trials of its lead compound up and running in the first quarter of 2017.
MELBOURNE, Australia – The Australian government is injecting more funding into its life sciences sector to help it become more globally competitive in commercializing products.
